𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II Pilot Study of KW-2189 in Patients with Advanced Renal Cell Carcinoma

✍ Scribed by Eric J. Small; Robert Figlin; Daniel Petrylak; David J. Vaughn; Oliver Sartor; Ivan Horak; Rosemarie Pincus; Alton Kremer; Chris Bowden

Book ID
110234855
Publisher
Springer US
Year
2000
Tongue
English
Weight
52 KB
Volume
18
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Phase II study of irinotecan in patien
A Phase II study of irinotecan in patients with advanced renal cell carcinoma
✍ Karim Fizazi; FrΓ©dΓ©ric Rolland; Christine Chevreau; Jean-Pierre Droz; Dominique πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 3 views

## Abstract ## BACKGROUND Patients with disseminated renal cell carcinoma (RCC) have a poor outcome, and the disease is considered highly resistant to chemotherapy. Irinotecan is an active drug in the treatment of a number of neoplastic diseases and is not concerned with the multidrug‐resistance p